This editorial maps RiMS’s activities and aligns it with the WHO’s 10 priority areas, assessing its contributions and identifying gaps to enhance the understanding of RiMS’ role in contributing to these priorities and to inform the adaptation of strategic action plans to ensure alignment with global priorities.
More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.